BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20190332)

  • 1. Therapeutic implications of the pathophysiology of COPD.
    Macklem PT
    Eur Respir J; 2010 Mar; 35(3):676-80. PubMed ID: 20190332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiopathology of acute respiratory failure in COPD and asthma].
    Mergoni M; Rossi A
    Minerva Anestesiol; 2001 Apr; 67(4):198-205. PubMed ID: 11376510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
    Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
    Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does mechanical injury of the peripheral airways play a role in the genesis of COPD in smokers?
    Milic-Emili J
    COPD; 2004 Apr; 1(1):85-92. PubMed ID: 16997741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breathing pattern and chest wall volumes during exercise in patients with cystic fibrosis, pulmonary fibrosis and COPD before and after lung transplantation.
    Wilkens H; Weingard B; Lo Mauro A; Schena E; Pedotti A; Sybrecht GW; Aliverti A
    Thorax; 2010 Sep; 65(9):808-14. PubMed ID: 20805177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
    Ora J; Laveneziana P; Ofir D; Deesomchok A; Webb KA; O'Donnell DE
    Am J Respir Crit Care Med; 2009 Nov; 180(10):964-71. PubMed ID: 19897773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyspnea and activity limitation in COPD: mechanical factors.
    O'Donnell DE; Laveneziana P
    COPD; 2007 Sep; 4(3):225-36. PubMed ID: 17729066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
    Ozgur ES; Atis S; Kanik A
    Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of air-trapping in patients with COPD. Pathophysiological principle].
    Voshaar TH
    Med Klin (Munich); 2005 Oct; 100 Suppl 1():5-8. PubMed ID: 16422211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease.
    Eves ND; Petersen SR; Haykowsky MJ; Wong EY; Jones RL
    Am J Respir Crit Care Med; 2006 Oct; 174(7):763-71. PubMed ID: 16840742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (COPD).
    Grazzini M; Stendardi L; Gigliotti F; Scano G
    Respir Med; 2005 Nov; 99(11):1403-12. PubMed ID: 16210095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Ogawa T; Watanabe F; Arizono S
    Respir Med; 2007 Apr; 101(4):833-8. PubMed ID: 16962758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
    Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinflation and intrinsic positive end-expiratory pressure: less room to breathe.
    Krieger BP
    Respiration; 2009; 77(3):344-50. PubMed ID: 19141987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
    Cooper CB
    Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The major limitation to exercise performance in COPD is dynamic hyperinflation.
    O'Donnell DE; Webb KA
    J Appl Physiol (1985); 2008 Aug; 105(2):753-5; discussion 755-7. PubMed ID: 18678624
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperinflation and its management in COPD.
    Puente-Maestu L; Stringer WW
    Int J Chron Obstruct Pulmon Dis; 2006; 1(4):381-400. PubMed ID: 18044095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar dynamic hyperinflation during arm and leg exercise at similar ventilation in chronic obstructive pulmonary disease.
    Hannink JD; Van Helvoort HA; Dekhuijzen PN; Heijdra YF
    Med Sci Sports Exerc; 2011 Jun; 43(6):996-1001. PubMed ID: 21085035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.